316 related articles for article (PubMed ID: 21199169)
21. Green tea catechins: a fresh flavor to anticancer therapy.
Yu Y; Deng Y; Lu BM; Liu YX; Li J; Bao JK
Apoptosis; 2014 Jan; 19(1):1-18. PubMed ID: 24081390
[TBL] [Abstract][Full Text] [Related]
22. A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent.
Landis-Piwowar KR; Huo C; Chen D; Milacic V; Shi G; Chan TH; Dou QP
Cancer Res; 2007 May; 67(9):4303-10. PubMed ID: 17483343
[TBL] [Abstract][Full Text] [Related]
23. (-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells.
Kim M; Murakami A; Kawabata K; Ohigashi H
Carcinogenesis; 2005 Sep; 26(9):1553-62. PubMed ID: 15860507
[TBL] [Abstract][Full Text] [Related]
24. Novel mechanisms of anticancer activities of green tea component epigallocatechin- 3-gallate.
Zhang L; Wei Y; Zhang J
Anticancer Agents Med Chem; 2014; 14(6):779-86. PubMed ID: 24851882
[TBL] [Abstract][Full Text] [Related]
25. Anticarcinogenic activity of green tea polyphenols.
Komori A; Yatsunami J; Okabe S; Abe S; Hara K; Suganuma M; Kim SJ; Fujiki H
Jpn J Clin Oncol; 1993 Jun; 23(3):186-90. PubMed ID: 8350491
[TBL] [Abstract][Full Text] [Related]
26. Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells.
Gupta S; Ahmad N; Nieminen AL; Mukhtar H
Toxicol Appl Pharmacol; 2000 Apr; 164(1):82-90. PubMed ID: 10739747
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: structure-activity relationship and mechanisms involved.
Chung JY; Huang C; Meng X; Dong Z; Yang CS
Cancer Res; 1999 Sep; 59(18):4610-7. PubMed ID: 10493515
[TBL] [Abstract][Full Text] [Related]
28. Human hair growth enhancement in vitro by green tea epigallocatechin-3-gallate (EGCG).
Kwon OS; Han JH; Yoo HG; Chung JH; Cho KH; Eun HC; Kim KH
Phytomedicine; 2007 Aug; 14(7-8):551-5. PubMed ID: 17092697
[TBL] [Abstract][Full Text] [Related]
29. Green tea constituent (--)-epigallocatechin-3-gallate inhibits topoisomerase I activity in human colon carcinoma cells.
Berger SJ; Gupta S; Belfi CA; Gosky DM; Mukhtar H
Biochem Biophys Res Commun; 2001 Oct; 288(1):101-5. PubMed ID: 11594758
[TBL] [Abstract][Full Text] [Related]
30. Induction of CYP1A by green tea extract in human intestinal cell lines.
Netsch MI; Gutmann H; Schmidlin CB; Aydogan C; Drewe J
Planta Med; 2006 May; 72(6):514-20. PubMed ID: 16773535
[TBL] [Abstract][Full Text] [Related]
31. The specific anti-cancer activity of green tea (-)-epigallocatechin-3-gallate (EGCG).
Wang YC; Bachrach U
Amino Acids; 2002; 22(2):131-43. PubMed ID: 12395181
[TBL] [Abstract][Full Text] [Related]
32. Primary cancer prevention by green tea, and tertiary cancer prevention by the combination of green tea catechins and anticancer compounds.
Fujiki H; Sueoka E; Watanabe T; Suganuma M
J Cancer Prev; 2015 Mar; 20(1):1-4. PubMed ID: 25853098
[TBL] [Abstract][Full Text] [Related]
33. Effect of Tea Polyphenol Compounds on Anticancer Drugs in Terms of Anti-Tumor Activity, Toxicology, and Pharmacokinetics.
Cao J; Han J; Xiao H; Qiao J; Han M
Nutrients; 2016 Dec; 8(12):. PubMed ID: 27983622
[TBL] [Abstract][Full Text] [Related]
34. Molecular Targets of Epigallocatechin-Gallate (EGCG): A Special Focus on Signal Transduction and Cancer.
Negri A; Naponelli V; Rizzi F; Bettuzzi S
Nutrients; 2018 Dec; 10(12):. PubMed ID: 30563268
[TBL] [Abstract][Full Text] [Related]
35. Combination cancer chemoprevention with green tea extract and sulindac shown in intestinal tumor formation in Min mice.
Suganuma M; Ohkura Y; Okabe S; Fujiki H
J Cancer Res Clin Oncol; 2001 Jan; 127(1):69-72. PubMed ID: 11206275
[TBL] [Abstract][Full Text] [Related]
36. Effect of green tea on pharmacokinetics of 5-fluorouracil in rats and pharmacodynamics in human cell lines in vitro.
Qiao J; Gu C; Shang W; Du J; Yin W; Zhu M; Wang W; Han M; Lu W
Food Chem Toxicol; 2011 Jun; 49(6):1410-5. PubMed ID: 21440026
[TBL] [Abstract][Full Text] [Related]
37. Tea catechin synergies in inhibition of cancer cell proliferation and of a cancer specific cell surface oxidase (ECTO-NOX).
Morré DJ; Morré DM; Sun H; Cooper R; Chang J; Janle EM
Pharmacol Toxicol; 2003 May; 92(5):234-41. PubMed ID: 12753411
[TBL] [Abstract][Full Text] [Related]
38. Green tea: cancer preventive beverage and/or drug.
Fujiki H; Suganuma M; Imai K; Nakachi K
Cancer Lett; 2002 Dec; 188(1-2):9-13. PubMed ID: 12406542
[TBL] [Abstract][Full Text] [Related]
39. Catechin hydrate inhibits proliferation and mediates apoptosis of SiHa human cervical cancer cells.
Al-Hazzani AA; Alshatwi AA
Food Chem Toxicol; 2011 Dec; 49(12):3281-6. PubMed ID: 21967781
[TBL] [Abstract][Full Text] [Related]
40. Cancer Prevention with Green Tea and Its Principal Constituent, EGCG: from Early Investigations to Current Focus on Human Cancer Stem Cells.
Fujiki H; Watanabe T; Sueoka E; Rawangkan A; Suganuma M
Mol Cells; 2018 Feb; 41(2):73-82. PubMed ID: 29429153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
